Substance abuse is an ever-present problem, encompassing the misuse of both legal and illegal substances. It encompasses a broad range of substances including alcohol, tobacco, prescription drugs, and illegal drugs such as cocaine, heroin, and methamphetamine. While some people can consume these substances without developing an addiction, substance abuse manifests when an individual can no longer control their consumption and experience a range of harsh physical and mental effects. At its core, substance abuse involves a person’s inability to control their consumption and creating a cycle of physical and psychological dependence. According to the DSM-5, the diagnostic manual of the American Psychiatric Association, a person is considered to be abusing a substance when they continue taking drugs despite adverse consequences and when use causes significant impairments in the performance of daily activities. When it comes to the effects of substance abuse, it often comes down to the amount and type of substance the individual is consuming. Physical effects can range from nausea and headaches to seizures and organ failure. Mental effects can include mood swings, depression, paranoia, and psychosis. Social effects can vary widely, and might include relationship issues, legal trouble, and financial burdens. Substance abuse can have a devastating impact on an individual’s life, but the good news is that there is help available. Psychotherapy, support groups, and medication-assisted treatment are some of the most common treatments for substance abuse. People can also seek out help from a variety of organizations dedicated to fighting addiction and helping those affected bring it into remission. With the right kind of support, those suffering from substance abuse can find hope and lead healthy, fulfilling lives.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States